Minehiko Inomata
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 04, 2025
TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung Cancer.Zenta Seto, Minehiko Inomata, Akira Noguchi
|Apr 26, 2023
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.Minehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa
|Dec 01, 2021
Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer.Zenta Seto, Naoki Takata, Nozomu Murayama
|Dec 01, 2020
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy.Minehiko Inomata, Kenji Azechi, Naoki Takata
|Sep 21, 2018
Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy.Minehiko Inomata, Takahiro Hirai, Zenta Seto
Pageof 1
